AstraZeneca PLC


  • Wall Street to digest China reforms, Ukraine vote Monday, 12 May 2014 | 8:31 AM ET

    U.S. stock index futures signaled a higher open on Monday, after the Dow Jones's all-time high close on Friday.

  • Early movers: PF, AZN, PFE, CS, P & more Monday, 12 May 2014 | 7:46 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • LONDON, May 12- Pfizer defended the business case behind its plan to acquire AstraZeneca on Monday and questioned the UK drugmaker's ability to stand alone for much longer as the New York- based group's CEO prepared for a grilling from British lawmakers.

  • US STOCKS-Futures rise, S&P 500 near record Monday, 12 May 2014 | 7:18 AM ET

    *Hillshire to buy Pinnacle Foods for $6.6 billion. NEW YORK, May 12- U.S. stock index futures rose on Monday, putting the S&P 500 within striking distance of record levels, though geopolitical concerns in the Ukraine could cap gains.

  • Gov. Jack Markell, Governor, (D-Del.), discusses his concerns about Pfizer's proposed acquisition of AstraZeneca.

  • Pfizer says its commitments to UK legally binding Monday, 12 May 2014 | 5:31 AM ET

    PFIZER SAYS ITS COMMITMENTS TO UK LEGALLY BINDING@. LONDON, May 12- U.S. drugmaker Pfizer said on Monday its commitments to preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca were legally binding.

  • LONDON, May 12- U.S. drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.

  • CNBC's Catherine Boyle outlines key events this week that will impact Pfizer's struggle to acquire U.K. rival AstraZeneca.

  • Which M&A deal is best for shareholders? Monday, 12 May 2014 | 12:44 AM ET

    Which M&A deal represents the best value for shareholders?

  • Big week ahead in Pfizer's fight for AstraZeneca Sunday, 11 May 2014 | 11:11 AM ET

    Pfizer kicked off the most important week to date in its struggle to gain control of U.K. rival AstraZeneca.

  • LONDON, May 11- British Prime Minister David Cameron said on Sunday he had made very good progress in securing guarantees from Pfizer over the U.S. drugmaker's $106 billion bid to buy AstraZeneca.

  • Pfizer fights back against AZ takeover critics Sunday, 11 May 2014 | 6:12 AM ET

    Pfizer has launched a fight back against critics of its proposed takeover of AstraZeneca, but did not make any fresh promises on jobs or investment.

  • *$106 bln Pfizer bid stirs up political storm on job fears. LONDON, May 11- How British is AstraZeneca? With a French chief executive, Swedish chairman, 40 percent of its sales in the United States and 87 percent of its staff overseas, the answer is not simple.

  • *CEO says UK science a key attraction of AstraZeneca deal. LONDON, May 10- U.S. drugmaker Pfizer fought back on Saturday against criticism that its planned takeover of rival AstraZeneca would damage Britain's science base by saying strong UK research was a key reason for the deal.

  • LONDON, May 10- Britain is ready for "hard negotiation" to ensure Pfizer sticks to specific promises on jobs and science under the U.S. drugmaker's proposed takeover of AstraZeneca, its finance minister said. "I think it would be extraordinary not to engage with AstraZeneca or Pfizer," George Osborne told BBC radio on Saturday.

  • US politicians step up scrutiny of Pfizer bid Saturday, 10 May 2014 | 5:50 AM ET

    Pfizer's $106 billion takeover approach for AstraZeneca is facing mounting scrutiny as senior U.S. politicians weigh in.

  • BUSINESS-NEWS-SCHEDULE AT 1530 GMT / 11:30 AM ET Friday, 9 May 2014 | 11:35 AM ET

    Wal-Mart should face lawsuit over alleged Mexico bribery- U.S. judge. Wal-Mart Stores Inc should face a U.S. lawsuit accusing it of defrauding shareholders by concealing suspected corruption at its Mexico operations, even after learning that a damaging media report detailing alleged bribery was being prepared, a federal judge says.

  • Publicis CEO: Merger off as 'equality impossible' Friday, 9 May 2014 | 11:27 AM ET
    Publicis CEO Maurice Levy stands on the the floor of the New York Stock Exchange a day after announcing that Omnicom Group and Publicis Groupe will merge to form the world's largest advertising holding company on July 29, 2013 in New York City.

    Publicis CEO Maurice Levy has told CNBC that the decision to call off a $35 billion merger with U.S.-based Omnicom was "an issue of principle."

  • 3 big reasons to buy stocks now: Hedge fund pro Friday, 9 May 2014 | 9:39 AM ET
    Traders on the floor of the New York Stock Exchange.

    There are a lot of tailwinds for the stock market right now, hedge fund manager Dan Arbess tells CNBC.

  • U.S. stock index futures pointed to a lower open on Wall Street on Friday, ahead of first quarter results from Liberty Interactive and Ralph Lauren.